Literature DB >> 11950754

Antiplatelet therapy and atherosclerotic events. Commentary is inaccurate.

Cathie Sudlow, Peter Sandercock, Charles Warlow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11950754      PMCID： PMC1122854     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Preventing atherosclerotic events with aspirin.

Authors:  John G F Cleland
Journal:  BMJ       Date:  2002-01-12

2.  Gathering intelligence on antiplatelet drugs: the view from 30 000 feet. When combined with other information overviews lead to conviction.

Authors:  Muredach Reilly; Garret A FitzGerald
Journal:  BMJ       Date:  2002-01-12

3.  Article makes simple errors and could cause unnecessary deaths.

Authors:  Colin Baigent; Rory Collins; Richard Peto
Journal:  BMJ       Date:  2002-01-19

4.  Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Hayden; Michael Pignone; Christopher Phillips; Cynthia Mulrow
Journal:  Ann Intern Med       Date:  2002-01-15       Impact factor: 25.391

5.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12
  5 in total
  1 in total

1.  Acute coronary disease Athero-Inflammation: Therapeutic approach.

Authors:  Raul Altman
Journal:  Thromb J       Date:  2003-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.